NASDAQ: CYTK
Cytokinetics Inc Earnings & Revenue

CYTK past revenue growth

How has CYTK's revenue growth performed historically?
Company
-60.33%
Industry
960.59%
Market
42.08%
CYTK's revenue has grown slower... subscribe to Premium to read more.
Performance
CYTK's revenue has grown slower... subscribe to Premium to read more.
Performance
CYTK's revenue growth is slowing... subscribe to Premium to read more.
Performance

CYTK earnings and revenue history

Current Revenue
$21.6M
Current Earnings
-$228.7M
Current Profit Margin
-1,061.1%

CYTK Return on equity

Current Company
-204.7%
Current Industry
8.9%
Current Market
93.9%
CYTK's Return on Equity (-204.7%)... subscribe to Premium to read more.
Performance

CYTK Return on assets

Current Company
-36.5%
Current Industry
3%
CYTK is generating lower Return... subscribe to Premium to read more.
Performance

CYTK Return on capital employed

Current Company
-28.45%
Current Industry
10.9%
CYTK has gotten more efficient... subscribe to Premium to read more.
Performance

CYTK earnings dates

Next earnings date
Feb 23, 2022

Cytokinetics Earnings & Revenue FAQ

What were CYTK's earnings last quarter?

On Invalid Date, Cytokinetics (NASDAQ: CYTK) reported Q3 2021 earnings per share (EPS) of -$0.95, up 1,800% year over year. Total Cytokinetics earnings for the quarter were -$76.09 million. In the same quarter last year, Cytokinetics's earnings per share (EPS) was -$0.05.

What was CYTK's earnings growth in the past year?

As of Q1 2022, Cytokinetics's earnings has grown null year over year. Cytokinetics's earnings in the past year totalled -$228.67 million.

What is CYTK's earnings date?

Cytokinetics's earnings date is Invalid Date. Add CYTK to your watchlist to be reminded of CYTK's next earnings announcement.

What was CYTK's revenue last quarter?

On Invalid Date, Cytokinetics (NASDAQ: CYTK) reported Q3 2021 revenue of $5.44 million up 86.96% year over year. In the same quarter last year, Cytokinetics's revenue was $41.69 million.

What was CYTK's revenue growth in the past year?

As of Q1 2022, Cytokinetics's revenue has grown -60.33% year over year. This is 1,020.91 percentage points lower than the US Biotechnology industry revenue growth rate of 960.59%. Cytokinetics's revenue in the past year totalled $21.55 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.